Northwestern Medicine scientists have identified a novel strategy for reducing the side effects of the drug levodopa, which is commonly used to treat the stiffness, tremors and poor muscle control of Parkinson’s disease.
Northwestern scientists have developed a microfluidic device to sort neural stem cell populations, making them easier to study, a tool may lead to a better understanding of how stem cells function.
SchizConnect, the first neuroimaging meta-database dedicated to clinical schizophrenia research, will allow scientists to see broader results across many more subjects than ever before.
Northwestern Medicine scientists pinpointed a master switch that orchestrates thousands of genetic pathways an internal body clock takes to dictate how and when our pancreas must produce insulin and control blood sugar.
Northwestern Medicine scientists have shown for the first time that the Myosin 9b gene is correlated with lung cancer tumor formation and metastasis.
A new multidisciplinary Huntington’s disease clinic is a one-stop shop where patients can receive comprehensive care to manage their symptoms and improve their quality of life.
A recent study sheds new light on how an animal’s biological clock wakes it up in the morning and puts it to sleep at night.
Recordings of neurons in a little-studied part of the brain associated with memory show an unexpected increase in activity in older brains, a finding that may suggest a new target for therapies to combat memory loss.
A study co-authored by Northwestern Medicine scientist Rintaro Hashizume, MD, PhD, identified the EAG2 potassium channel as a target for treating medulloblastoma.
Northwestern Medicine scientists have found evidence that a protein that has a genetic link to ALS and other neurodegenerative diseases destroys mitochondria in neurons.